Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A.K. Trampe(University of Lübeck), Andrew Chan(Infosys (India)), Aiden Haghikia(Friedrich-Alexander-Universität Erlangen-Nürnberg), Susan Goelz(Biogen (United States)), Heinz Wiendl(University Medical Center Freiburg), Andreas Ziegler(Universität Hamburg), Kerstin Hellwig(St. Josef-Hospital), Ralf Gold(St. Josef-Hospital), Claudia Hemmelmann(University of Lübeck), Anke Stroet(University of Lübeck)
Cited by 128
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706